• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Pharmaceutical Focus: A Look at Combination Products

    The Printed World: Additive Manufacturing in Medtech

    The Lost Year: 2020 Year in Review

    Extrusion Evolution

    Little Big Parts: Micromolding Under the Microscope
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    Eitan Medical Receives FDA Clearance for Sapphire Infusion System

    Researchers Successfully ‘Fine Tune’ New Thermoplastic Biomaterial

    RSIP Vision Announces Versatile Medical Image Segmentation Tool

    Vance Street Capital Adds Operating Partner

    Haemonetics to Acquire Cardiva for Up to $510M
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Pharmaceutical Focus: A Look at Combination Products

    The Printed World: Additive Manufacturing in Medtech

    The Lost Year: 2020 Year in Review

    Extrusion Evolution

    Little Big Parts: Micromolding Under the Microscope
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Fixing Face Mask Form and Function

    The Heart of the Matter: Trends in Cardiology

    Virtually the Same? The Challenges of Online Conferences

    Digital Health Delivers During a Year for the Ages

    Advanced Technology for Staking and Swaging Medical Plastics
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    FUTEK Advanced Sensor Technology Inc.

    MW Life Sciences

    Concise Engineering

    Medicoil

    K-Tube Technologies
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Meeting Critical Ventilator Product Requirements Amid Pandemic

    Impact of COVID-19 on the Medtech Supply Chain

    Finding the Upside to a Challenging Year

    Preparing Your Design Controls for FDA Approval

    A 'Trial and Error' Approach to Micromolded Parts
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    maxon

    PTI Engineered Plastics Inc.

    K-Tube Technologies

    FUTEK Advanced Sensor Technology Inc.

    Medicoil
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    New Blood Test Rapidly Detects Signs of Pancreatic Cancer

    Researchers used an electronic chip-based system to extract exosomes directly from blood in minutes.

    New Blood Test Rapidly Detects Signs of Pancreatic Cancer
    UC San Diego researchers have developed a test to screen for pancreatic cancer in a drop of blood. Images courtesy of David Baillot/UC San Diego Jacobs School of Engineering.
    Related CONTENT
    • Sera Prognostics Partners with Anthem and HealthCore
    • Pharmaceutical Focus: A Look at Combination Products
    • Ingestible Capsule May Help Demystify the Gut-Brain Axis
    • Biomarker Strategies' Names Chief Operating and Science Officer
    • FDA Greenlights First Blood Test for Novel Red Meat Allergy
    University of California - San Diego05.18.18
    Pancreatic cancer is expected to become the second deadliest cancer in the United States by 2030. It is tough to cure because it is usually not discovered until it has reached an advanced stage. But a new diagnostic test developed by researchers at UC San Diego shows promise for detecting the disease earlier.
     
    The test, which is at the proof-of-concept stage, can rapidly screen a drop of blood for biomarkers of pancreatic cancer. It can provide results in less than an hour. The findings were published recently in the journal ACS Nano.
     
    "An important step towards being able to cure diseases that come out of nowhere, like pancreatic cancer, is early detection," said first author Jean Lewis, an assistant project scientist in the Department of Nanoengineering at UC San Diego. "We envision that in the future, physicians might perform this type of test using a quick finger stick to diagnose patients who may not know they have the disease yet."
     
    Blood tests for early cancer detection, known as liquid biopsies, are a hot topic in research. They have the potential to detect cancer early on without having to do invasive surgical procedures like tumor biopsies. To screen for pancreatic cancer in the blood, researchers are developing new methods that involve collecting and analyzing nano-sized biological structures called exosomes, which are released from all cells in the body, including cancer cells. Exosomes contain proteins and genetic material that can serve as biomarkers for detecting cancers.
     
    But because exosomes are so tiny and fragile, they are hard to isolate from blood. Current methods to extract exosomes are time-consuming and require that blood samples be pretreated or diluted prior to use.
     
    The test developed by UC San Diego researchers uses an electronic chip-based system to extract exosomes directly from blood in minutes. "We can use just a drop of blood as is—no extra processing required," said Lewis. "We can also analyze the exosomes right there on the spot and show whether they carry any of the cancer biomarkers we are looking for."
     
    Lewis worked on this project as part of a cross-disciplinary collaboration between nanotechnology researchers at the UC San Diego Jacobs School of Engineering and clinicians at Moores Cancer Center at UC San Diego Health. The collaboration is led by Michael Heller, professor emeritus of nanoengineering at the UC San Diego Jacobs School of Engineering, who is now at Oregon Health & Science University's Knight Cancer Institute.
     
    "The innovation of this work is that it essentially combines all the complex, lengthy steps of sample preparation, exosome isolation and final assay interpretation required by other platforms into one seamless 'sample-to-answer' device," said Heller. "We've developed a prototype platform that has the potential to translate into a handheld, rapid and relatively inexpensive point of care testing device for pancreatic cancer."


    Lab setup used to test blood samples.

    It Only Takes a Drop
    The test is simple. Apply a drop of blood on a small electronic chip, turn the current on, wait several minutes, add fluorescent labels and look at the results under a microscope. If a blood sample tests positive for pancreatic cancer, bright fluorescent circles will appear.
     
    "This test could be used as a primary screening strategy to identify patients who would subsequently need to undergo more expensive and invasive diagnostic methods like a CT scan, MRI or endoscopy," said Dr. Rebekah White, surgical oncologist and associate professor of surgery at Moores Cancer Center.
     
    The chip used in this test works by applying an alternating electric current, which selectively pulls nano-sized particles like exosomes out of the blood and deposits them onto tiny electrodes on the chip's surface. Larger blood particles get washed away while smaller ones such as exosomes are left behind. Researchers then apply fluorescently labeled antibodies that specifically target two protein biomarkers for pancreatic cancer: glypican-1 and CD63. If these biomarkers are present, brightly colored circles where the antibodies bind can be seen under a microscope, indicating a positive result. This entire process can be done in less than an hour.

    So far, the team has only tested this system on a small sample set of patients. In an initial validation study on a group of 31 patients, the chip was able to flag the blood samples of 20 patients with pancreatic cancer from those of 11 patients without cancer.
     
    Working Toward Early Detection
    The team cautions that the biomarker levels screened in this study might not represent those in early stage cancer. "How small are these biomarker levels between stage 0 and stage 1 cancer? And how can we make our technology sensitive enough to detect these amounts? We're doing more research to get a good handle on these questions," said Heller.
     
    Next steps also include studies on a larger sample size, screening more samples from patients at various stages of cancer, and optimizing and validating this technology for early cancer detection. "A challenge in doing these studies is getting hold of early stage blood samples, when patients don't even know they have the disease yet," said Lewis.
     
    "Future work would entail obtaining blood samples from patients that have high risk factors for pancreatic cancer—new onset diabetes or a family history of it, smoking or obesity—and continue sampling their blood over an extended period of time. Of the patients that are subsequently diagnosed, we can go back and analyze their pre-diagnostic blood samples to see how early on we can detect cancer biomarkers," said White.
     
    The researchers are also exploring other blood-based biomarkers—in addition to glypican-1 and CD63—to improve this system's accuracy and sensitivity for pancreatic cancer detection.
     
    The technology for the chip-based system was initially developed by UC San Diego Jacobs School of Engineering alumnus Raj Krishnan during his bioengineering doctoral research in Heller's lab on identifying cancer biomarkers from blood using alternating electric currents. Krishnan co-founded and is CEO of San Diego-based company Biological Dynamics, a spinout from Heller's lab that licensed the technology in 2010. Biological Dynamics has since been developing novel diagnostic systems based on chips that use alternating electric currents to isolate nanoparticles, DNA and other molecules directly from blood and other biofluids. In the current ACS Nano paper, UC San Diego researchers used the exosome-isolating capability of Biological Dynamics technology to develop a custom assay for pancreatic cancer detection.
     
    Find more information on the study here.
    Related Searches
    • screening
    • institute
    • microscope
    • testing
    Related Knowledge Center
    • Diagnostics
    Suggested For You
    Sera Prognostics Partners with Anthem and HealthCore Sera Prognostics Partners with Anthem and HealthCore
    Pharmaceutical Focus: A Look at Combination Products Pharmaceutical Focus: A Look at Combination Products
    Ingestible Capsule May Help Demystify the Gut-Brain Axis Ingestible Capsule May Help Demystify the Gut-Brain Axis
    Biomarker Strategies Biomarker Strategies' Names Chief Operating and Science Officer
    FDA Greenlights First Blood Test for Novel Red Meat Allergy FDA Greenlights First Blood Test for Novel Red Meat Allergy
    Abbott’s COVID-19 Antibody Blood Test Gains EUA for Use on Alinity i System Abbott’s COVID-19 Antibody Blood Test Gains EUA for Use on Alinity i System
    Blood Test May Help Doctors Catch Pancreatic Cancer Early Blood Test May Help Doctors Catch Pancreatic Cancer Early
    Engineer Develops 3D Printer that Can Create Complex Biological Tissues Engineer Develops 3D Printer that Can Create Complex Biological Tissues
    Biological Dynamics Names Two to its Board of Directors Biological Dynamics Names Two to its Board of Directors
    FDA OKs Roche FDA OKs Roche's cobas Zika Test to Screen Multiple Pooled Blood or Plasma Donations
    TGen Develops Quality Control Test for Detecting Cancer in Blood TGen Develops Quality Control Test for Detecting Cancer in Blood
    Clinical Trial Tests Clinical Trial Tests 'Tattoo Sensor' as Needleless Glucose Monitor
    Chip-Based Multiple Myeloma Blood Test Could Eliminate Need for Bone Biopsies Chip-Based Multiple Myeloma Blood Test Could Eliminate Need for Bone Biopsies
    New Blood Test Can Predict TB Onset Up to Two Years in Advance New Blood Test Can Predict TB Onset Up to Two Years in Advance
    New Blood Test Can Help Identify People at Risk for Developing Alzheimer New Blood Test Can Help Identify People at Risk for Developing Alzheimer's

    Related Breaking News

    • Diagnostics
      RSIP Vision Announces Versatile Medical Image Segmentation Tool

      RSIP Vision Announces Versatile Medical Image Segmentation Tool

      Delivers efficient anatomical measurements and better treatment options.
      RSIP Visions 01.20.21

    • Diagnostics
      Thermo Fisher Buys Mesa Biotech for $450M

      Thermo Fisher Buys Mesa Biotech for $450M

      Mesa Biotech developed, commercialized a PCR-based rapid POC testing platform for detecting infectious diseases.
      PR Newswire 01.20.21

    • Diagnostics
      Owlstone Medical Introduces Breath Biopsy Panel for Respiratory Diseases

      Owlstone Medical Introduces Breath Biopsy Panel for Respiratory Diseases

      Supports research to distinguish between different types of chronic inflammatory airway diseases.
      Owlstone Medical 01.19.21


    • Cardiovascular | Diagnostics
      FDA OKs MRI for Impulse Dynamics

      FDA OKs MRI for Impulse Dynamics' Optimizer CCM Delivery Systems

      FDA clears potential hurdle for many heart failure patients.
      Business Wire 01.19.21

    • Diagnostics
      Rapid Antigen Tests Manufacturer Acquires BIOLAB

      Rapid Antigen Tests Manufacturer Acquires BIOLAB

      Deal will create jobs and increase Innova's U.S. COVID-19 test kit manufacturing capability.
      Innova Medical Group Inc. 01.14.21

    • Diagnostics
      PerkinElmer

      PerkinElmer's SARS-CoV-2 RT-PCR Assay Earns EUA for Asymptomatic Testing

      Gold-standard testing of individuals without COVID-19 symptoms key to controlling the spread.
      Business Wire 01.14.21


    • Diagnostics
      High-Volume COVID Antigen Test Receives FDA EUA

      High-Volume COVID Antigen Test Receives FDA EUA

      Ortho’s Vitros can run up to 130 tests per hour and helps address testing backlogs, supply shortages, and delayed results.
      Ortho Clinical Diagnostics 01.13.21

    • Diagnostics
      Researchers Develop Chip That Can Detect COVID-19 Antibodies in a Minute

      Researchers Develop Chip That Can Detect COVID-19 Antibodies in a Minute

      New diagnostic platform could be a valuable tool for detecting exposure to multiple viruses.
      Bob Marcotte, University of Rochester 01.13.21

    • Diagnostics
      Abbott to Supply Additional 30M COVID-19 Tests to U.S. Gov

      Abbott to Supply Additional 30M COVID-19 Tests to U.S. Gov't

      Company is in final stages of completing its self-funded capacity expansion across U.S. manufacturing sites.
      PR Newswire 01.13.21


    • Diagnostics
      Olympus and Hitachi Sign Five-Year Contract

      Olympus and Hitachi Sign Five-Year Contract

      Will jointly develop Endoscopic Ultrasound Systems.
      Olympus Corporation 01.11.21

    • Diagnostics
      ForaCare Suisse AG Launches COVID-19 Antigen Rapid Test

      ForaCare Suisse AG Launches COVID-19 Antigen Rapid Test

      Provides fast, accurate, and easy-to-interpret test results.
      PRNewswire 01.11.21

    • Diagnostics | Neurological
      FDA OKs Abbott

      FDA OKs Abbott's First-of-Its-Kind Rapid, Handheld TBI Test

      Produces a result within 15 minutes after a plasma sample is inserted.
      Abbott Laboratories 01.11.21


    • Diagnostics
      SARS-CoV-2 Mutation Prompts FDA Alert

      SARS-CoV-2 Mutation Prompts FDA Alert

      Impact remains low, but false negative results can occur with any molecular test.
      U.S. Food and Drug Administration 01.11.21

    • Diagnostics
      CareDx Partners with IDbyDNA

      CareDx Partners with IDbyDNA

      Will develop AlloID, a transplant patient-specific metagenomic infectious disease test platform.
      Globe Newswire 01.08.21

    • Diagnostics
      Siemens Healthineers’ Laboratory-Based IL-6 Assay Receives EUA

      Siemens Healthineers’ Laboratory-Based IL-6 Assay Receives EUA

      Helps identify severe inflammatory immune responses in patients confirmed to have COVID-19.
      Siemens Healthineers 01.08.21


    Trending
    • Telemedicine, Regulatory Changes To Characterize Medtech Industry In 2021
    • Philips Buys Capsule Technologies In $635M Deal
    • Cytotron Gains Breakthrough Status To Treat Breast, Liver, And Pancreatic Cancers
    • Top 10 Trends In The Medical Device And Equipment Industry
    • Haemonetics To Acquire Cardiva For Up To $510M
    Breaking News
    • Eitan Medical Receives FDA Clearance for Sapphire Infusion System
    • Researchers Successfully ‘Fine Tune’ New Thermoplastic Biomaterial
    • RSIP Vision Announces Versatile Medical Image Segmentation Tool
    • Vance Street Capital Adds Operating Partner
    • Haemonetics to Acquire Cardiva for Up to $510M
    View Breaking News >
    CURRENT ISSUE

    November/December 2020

    • Pharmaceutical Focus: A Look at Combination Products
    • The Printed World: Additive Manufacturing in Medtech
    • The Lost Year: 2020 Year in Review
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Ingredient Manufacturers Discuss the E-Sports Market
    Euromonitor Names Top Ten Trends for 2021
    Study Highlights Differences Between EPA's and DHA's Effect on Sleep
    Coatings World

    Latest Breaking News From Coatings World

    IGL Coatings Launches Graphene Reinforced Dual System Ceramic Coating
    Miller Paint Declares Simple Serenity its 2021 Color of the Year
    TAUBMANS Paint by PPG Releases ‘Chromatic Joy’ Palettes
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Eitan Medical Receives FDA Clearance for Sapphire Infusion System
    Researchers Successfully ‘Fine Tune’ New Thermoplastic Biomaterial
    RSIP Vision Announces Versatile Medical Image Segmentation Tool
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Global Biosciences Co. Selects ValGenesis VLMS
    Eisai Appoints Chief Clinical Officer of Oncology Biz
    Nexelis Acquires GSK Vax Lab in Marburg
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Top Beauty Brands in the World—And Most Loved Fragrances
    P&G Reports Q2 Results
    A Lacquering Technique Makes Very Good Girl by Carolina Herrera Shine
    Happi

    Latest Breaking News From Happi

    Flow Launches Collagen Waters
    Associations Congratulate Biden & Harris
    David Stanko Joins JPMS
    Ink World

    Latest Breaking News From Ink World

    Morancé Soudure France Adds Comexi F2 MC 10-color Flexo Press
    THIMM Group Installs 1st Koenig & Bauer CorruFLEX
    Cowan Graphics Adds Fujifilm Inca OnsetX3 HS
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Domino grows installation and service teams
    ABG keeps pace with demand with recruitment drive
    Acucote expands FSC-certified portfolio
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    First Quality Launches Incognito by Prevail
    Essity Launches Reusable Underwear Product
    Honeywell Delivered 225 Million Masks in December
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    DJO Acquires Trilliant Surgical
    FDA Breakthrough Device Designation Granted to Spiderwort's Spinal Cord Technology
    Bioventus Appoints SVP of Operations
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    UDC Subsidiary Adesis' Website Wins 2020 MarCom Platinum Award
    Roadsimple Modernizes Warehouse Ops with Zebra Technologies
    Graphene Flagship Launches Redesigned Website

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login